UK SACT Board (Formally UK Chemotherapy Board)

The UK SACT (Systemic Anti-Cancer Therapy) Board provides guidance, oversight and support for the continuing development of SACT services in the UK.

Netty Cracknell is an experienced consultant oncology pharmacist with over 22 years of practice across NHS and independent healthcare organisations in the UK. She is the Principal Pharmacist for Cancer Services at Lewisham and Greenwich NHS Trust and also holds a clinical leadership role supporting cancer pharmacy services within an NHS Integrated Care Board.

Netty is the Past President of the International Society of Oncology Pharmacy Practitioners (ISOPP) and previously served as Co-Chair of the UK Systemic Anti-Cancer Therapy (SACT) Board. She has held several national leadership positions within the British Oncology Pharmacy Association (BOPA) and has led numerous UK and international initiatives to advance oncology pharmacy practice and patient safety.

She is a Fellow of the Royal College of Pharmacy (FRCPharm) and a Fellow of the British Oncology Pharmacy Association (fBOPA). Her professional interests include digital innovation, medicines safety, workforce development, and improving the quality and accessibility of cancer services. She is particularly passionate about education and training, supporting the development of the pharmacy workforce and expanding equitable access to learning opportunities for professionals across the UK and internationally.

Joseph is the Education and Training Lead and Specialist Cancer Pharmacist at The Christie NHS Foundation Trust with a specialist clinical and research interest in colorectal cancer and care closer to home. He is also an independent prescriber within the colorectal cancer speciality. Joseph is an Honorary Clinical Lecturer in the Division of Pharmacy & Optometry at the University of Manchester (UoM) where he teaches on the Cancer programme for Undergraduates and Postgraduates. His background has vastly been in clinical practice and his patient facing role within the MDT has allowed him to initiate and progress applied health research projects in his area of practice to benefit patient care. His experience and accolades have allowed Joseph to be elected as Chair of the British Oncology Pharmacy Association (BOPA), elected as a member (and current Co-Chair) of the UK SACT Board, become a member of the UK Pharmacy Professional Leadership (UKPPL) Advisory Board and a Fellow of the Royal Pharmaceutical Society (RPS). Joseph is passionate about promoting excellence in pharmaceutical care of patients with cancer through education, research, and innovation.